Navigation Links
Dendreon Publishes Manuscript on CD54 as a Surrogate Marker of Antigen Presenting Cell Activation
Date:3/3/2008

harness the immune system to fight cancer. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Active cellular immunotherapy holds promise because it may provide patients with a meaningful clinical benefit, such as survival, combined with low toxicity. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com.

Except for historical information contained herein, this news release contains forward-looking statements that are subject to risks and uncertainties surrounding the efficacy of PROVENGE to treat men suffering from prostate cancer, risks and uncertainties surrounding the presentation of data to the FDA and approval of product applications by the FDA and risks and uncertainties inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics. Factors that may cause such differences include risks related to our limited operating history, risks associated with completing our clinical trials, the risk that the safety and/or efficacy results of existing clinical trials or from additional clinical trials for PROVENGE will not support approval for a biologics license, the risk that the FDA may interpret data differently than we do or require more data or a more rigorous analysis of data than expected, the risk that the FDA will not approve a product for which a biologics license has been applied, the risk that the results of a clinical trial for PROVENGE or other product may not be indicative of results obtained in a later clinical trial, risks that we may lack the financial resources and access to capital to fund required clinical trials or commercial
'/>"/>

SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Announces Webcast Presentation at UBS Life Sciences Conference
3. Dendreon Secures $130 Million Committed Equity Financing Facility
4. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
5. Dendreon Reports Third Quarter 2007 Financial Results
6. Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer
7. Dendreon Announces Webcast Presentation at BIO CEO & Investor Conference
8. Circulation Publishes MERLIN TIMI-36 Data Showing Safety and Anti-Arrhythmic Effects of Ranexa(R)
9. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
10. Consortium publishes Phase II map of human genetic variation
11. The Lancet Publishes Vasogens ACCLAIM Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... September 23, 2014 Proove Biosciences ... will be presenting research on the association between specific ... U.S. Psychiatric and Mental Health Congress’ 27th ... conference focuses on the theme of ‘Embracing Change.’ Mental ... a changing landscape. From the challenges presented by the ...
(Date:9/23/2014)... Manassas, VA (PRWEB) September 23, 2014 ... organization, is pleased to announce two important appointments to ... as Executive Vice President of Strategy and Technology and ... Director for the Standards Resource Center. Both roles are ... Raymond H. Cypess, President and CEO at ATCC described ...
(Date:9/23/2014)... and ANNAPOLIS JUNCTION, MD (PRWEB) September 23, 2014 ... research leader in personalized medicine, presented industry leading research ... misuse this past weekend at the American Academy ... The meeting took place in Phoenix, Arizona at the ... study on the linkage between gender and genetic predisposition ...
(Date:9/23/2014)... Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced three ... to $5 million. The orders are all odour control projects ... continue to see new orders coming in," said Peter ... has climbed to over $11 million." About ... company that designs, manufactures and distributes a comprehensive line of ...
Breaking Biology Technology:Proove Biosciences Will Be Exhibiting New Genetic Research at the 27th Annual US Psych Congress Scientific Program 2Proove Biosciences Will Be Exhibiting New Genetic Research at the 27th Annual US Psych Congress Scientific Program 3ATCC Announces New Appointments to its Leadership Team 2ATCC Announces New Appointments to its Leadership Team 3Proove Biosciences Will Be Exhibiting I.M.P.L.O.R.E Study at the American Academy of Pain Management 25th Annual Meeting 2Proove Biosciences Will Be Exhibiting I.M.P.L.O.R.E Study at the American Academy of Pain Management 25th Annual Meeting 3
... Pennsylvania and REHOVOT Israel, January 16, Rosetta ... today unveiled initial data relating to the ... which is,based on a simple blood draw, ... year. The,company,s scientists and collaborators have identified ...
... Varian, Inc.,(NasdaqGS: VARI) today announced a plan to ... to close certain facilities. , ... economic environment,we are taking proactive steps to reduce our ... while continuing to invest in new product,development and maintaining ...
... cells, vastly improved medical imaging techniques and lighter ... potential applications envisioned for organic electronics. ... Elisabetta Collini of University of Toronto,s Department of ... to new insights into the way molecules absorb ...
Cached Biology Technology:Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Identified Candidate MicroRNA Biomarkers in Serum 2Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Identified Candidate MicroRNA Biomarkers in Serum 3Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Identified Candidate MicroRNA Biomarkers in Serum 4Varian, Inc. Announces Cost Reduction Plan 2U of T chemistry discovery brings organic solar cells a step closer 2
(Date:9/23/2014)... Ill. Scientists have scoured cow rumens and termite ... cell walls for the production of next-generation biofuels, but ... in the human lower intestine, researchers report. , Their ... the National Academy of Sciences , is the first ... microbes in the human gut can digest fiber, breaking ...
(Date:9/23/2014)... essential in the development of animals and plants. The ... information be translated in a reliable manner to give ... French-flag model of stripe formation is a classic paradigm ... colours of the French flag, is caused by a ... middle or low concentrations of the morphogen a "blue", ...
(Date:9/23/2014)... Sept. 23, 2014 Research and Markets ... Market Forecast and Opportunities, 2019" report to their ... used for enhancing security and protection in private as ... . The country,s government is focusing on using biometric ... and other national IDs that are of crucial importance ...
Breaking Biology News(10 mins):Search for better biofuels microbes leads to the human gut 2Search for better biofuels microbes leads to the human gut 3Recreating the stripe patterns found in animals by engineering synthetic gene networks 2India Biometrics Market Forecast and Opportunities, 2019 2India Biometrics Market Forecast and Opportunities, 2019 3
... discovered the critical sequence of events by which insulin ... The study, appearing in the May 9 Journal of ... Institute of Child Health and Human Development and the ... , “This finding provides useful information for understanding disorders ...
... lipid membrane. The membrane is studded with many hundreds ... into and out of the cell. Such membrane proteins ... and make the nervous system work. Scientists at Stockholm ... membrane proteins in the enteric bacterium Escherichia coli. Their ...
... to migrate to the appropriate locations in the brain and ... in an intricate network. Growth cones, structures in the tips ... right direction, guided by a complex set of signals from ... axons to extend and grow in a particular direction; others ...
Cached Biology News:NIH Researchers Discover How Insulin Allows Entry of Glucose Into Cells 2Cerebral navigation: How do nerve fibers know what direction to grow in? 2
... Tray (3 per pack), 1. ... blot processing.Automated staining of Coomassie Blue ... nucleic acid analysis.Prepares blots for high ... control of protocol, solution, volume, and ...
... 1 g. High quality kits ... preparation that give consistent and ... and tissues.Clean up samples from ... Accurately quantitate protein for first-dimension ...
GOAT ANTI CARICA PAPAYA PAPAIN...
PAb to Hu-IFN-Alpha/Beta R2 [(IFNAR2) CD118], Rabbit Serum, neutralizing Binds to but does not neutralize human interferon alpha/beta receptor...
Biology Products: